Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)

Treace Medical Concepts (TMCI) reported Preferred Shares of $7.9 million for Q1 2021, little changed quarter-over-quarter from $7.9 million in Q4 2020.

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021) Analysis & Trends

Treace Medical Concepts has reported Preferred Shares for 2 years, with the latest figure at $7.9 million in Q1 2021.

  • For the quarter ending Q1 2021, Preferred Shares changed N/A year-over-year to $7.9 million; the trailing twelve-month figure through Mar 2021 stood at $7.9 million (changed N/A YoY), and the FY2020 full-year result was $7.9 million, changed N/A from the prior year.
  • Preferred Shares for Q1 2021 stood at $7.9 million, roughly flat from $7.9 million in the prior quarter.
  • The five-year high for Preferred Shares was $7.9 million in Q4 2020, with the low at $7.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Treace Medical Concepts 274.20 Mn 222.34 Mn 37.41 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 7.94 Mn
Dec 31, 2020 7.94 Mn